Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase

Virology

Volumn 243, Issue 1, 1998, Pages 1-11

  Porter, Donna C ^b   Ansardi, David C ^b   Wang, Jun ^b   McPherson, Sylvia ^a   Moldoveanu, Zina ^b   Morrow, Casey D ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; LUCIFERASE; VIRUS RNA;

ARTICLE; ENCAPSULATION; ENTEROVIRUS; ENZYME ACTIVITY; GENETIC TRANSFECTION; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; RNA REPLICATION; VIRUS CAPSID;

ANIMALIA; BOVINAE; BOVINE ENTEROVIRUS; COXSACKIEVIRUS; DNA VIRUSES; HUMAN ENTEROVIRUS 70; HUMAN POLIOVIRUS 1; MIRIDAE; POLIOVIRUS; RNA VIRUSES; VACCINIA; VACCINIA VIRUS;

EID: 0032579846     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9046     Document Type: Article

References (36)

1. Anderson M. J., Moldoveanu Z., Fletcher T. M. III, McPherson S., Porter D. C., Morrow C. D. Characterization of the expression and immunogenicity of poliovirus replicons which encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins. AIDS Res. Hum. Retroviruses. 13:1996a;53-62.
2. smm. Virology. 219:1996b;140-149.
3. Andino R., Rieckhof E., Achacoso P. L., Baltimore D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J. 12:1993;3587-3598.
4. Ansardi D. C., Moldoveanu Z., Porter D. C., Walker D. E., Conry R. M., LoBuglio A. F., McPherson S., Morrow C. D. Characterization of poliovirus replicons encoding carcinoembryonic antigen. Cancer Res. 54:1994;6359-6363.
5. Ansardi D. C., Porter D. C., Morrow C. D. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J. Virol. 65:1991;2088-2092.
6. Cole C. N. Defective interfering (DI) particles of poliovirus. Prog. Med. Virol. 20:1975;180-207.
7. Cole C. N., Baltimore D. Defective interfering particles of poliovirus. II. Nature of the defect. J. Mol. Biol. 76:1973a;325-361.
8. Cole C. N., Baltimore D. Defective interfering particles of poliovirus. III. Interference and enrichment. J. Mol. Biol. 76:1973b;345-361.
9. Cole C. N., Baltimore D. Defective interfering particles of poliovirus. IV. Mechanisms of enrichment. J. Virol. 12:1973c;1414-1426.
10. Cole C. N., Smoler D., Wimmer E., Baltimore D. Defective interfering particles of poliovirus. I. Isolation and physical properties. J. Virol. 7:1971;478-485.
11. Harris K. S., Hellen C. U. T., Wimmer E. Proteolytic processing in the replication of picornaviruses. Semin. Virol. 1:1990;323-333.
12. Kajigaya S., Arakawa H., Kuge S., Koi T., Imura N., Nomoto A. Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain. Virology. 142:1985;307-316.
13. Kaplan G., Racaniello V. R. Construction and characterization of poliovirus subgenomic replicons. J. Virol. 62:1988;1687-1696.
14. Kitamura N., Semler B. L., Rothberg P. G., Larsen G. R., Adler C. J., Dorner A. J., Emini E. A., Hanecak R. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (London). 291:1981;547-553.
15. Koch F., Koch G. The Molecular Biology of Poliovirus. 1985;Springer-Verlag, Vienna.
16. Kuhn R. J., Wimmer E. The replication of picornaviruses. Molecular Biology of Positive Strand RNA Viruses. 1987;Academic Press, London. p. 17-51.
17. Moldoveanu Z., Porter D. C., Lu A., McPherson S., Morrow C. D. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Vaccine. 13:1995;1013-1022.
18. Morrow C. D., Ansardi D. C., Porter D. C. Methods for the use of poliovirus vectors for gene delivery. Robbins P. Gene Therapy Protocols: Methods in Molecular Biology. 1996a;103-116 Humana, Totowa.
19. Morrow C. D., Moldoveanu Z., Anderson M. J., Porter D. C. Poliovirus replicons as a vector for mucosal vaccines. Kiyono H., McGhee J., Ogra P. Mucosal Vaccines. 1996b;137-144.
20. Morrow C. D., Porter D. C., Ansardi D. C. New methods to study poliovirus assembly and encapsidation of genomic RNA. Adolph K. W. Methods in Molecular Genetics. Viral Gene Techniques. 7:1995;299-314 Academic Press, Orlando.
21. Morrow C. D., Porter D. C., Ansardi D. C., Moldoveanu Z., Fultz P. N. New approaches for mucosal vaccines for AIDS: Encapsidation and serial passage of poliovirus replicons which express HIV-1 proteins upon infection. AIDS Res. Hum. Retroviruses. 10:1994;S61-S66.
22. Nicklin M. J. H., Kräusslich H. G., Toyoda H., Dunn J. J., Wimmer E. Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc. Natl. Acad. Sci. USA. 84:1987;4002-4006.
23. Nicklin M. J. H., Toyoda H., Murray M. G., Wimmer E. Proteolytic processing in the replication of polio and related viruses. BioTechnology. 4:1986;33-42.
24. Nomoto A., Jacobson A., Lee Y. F., Dunn J., Wimmer E. Defective interfering particles of poliovirus: mapping of deletion and evidence that the deletions in the genome of DI (1), (2) and (3) are located in the same region. J. Mol. Biol. 128:1975;179-196.
25. Novak J. E., Kirkegaard K. Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative stand in infected cells. J. Virol. 65:1991;3384-3387.
26. Palmenberg A. C. Proteolytic processing of picornaviral polyprotein. Annu. Rev. Microbiol. 44:1990;603-623.
27. Percy N., Barclay W. S., Sullivan M., Almond J. W. A poliovirus replicon containing the chloramphenicol acetyl-transferase gene can be used to study the replication and encapsidation of poliovirus RNA. J. Virol. 66:1992;5040-5046.
28. Porter D. C., Ansardi D. C., Choi W. S., Morrow C. D. Encapsidation of genetically engineered poliovirus mini-replicons which express HIV-1gagpol. J. Virol. 67:1993;3712-3719.
29. Porter D. C., Ansardi D. C., Morrow C. D. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type1gagin trans. J. Virol. 69:1995;1548-1555.
30. Porter D. C., Melsen L. R., Compans R. W., Morrow C. D. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag. J. Virol. 70:1996;2643-2649.
31. Porter D. C., Wang J., Moldoveanu Z., McPherson S., Morrow C. D. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin. Vaccine. 15:1997;257-264.
32. Racaniello V., Baltimore D. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science. 214:1981;916-919.
33. Reuer Q., Kuhn R. J., Wimmer E. Characterization of poliovirus clones containing lethal and nonlethal mutations in the genome-linked protein VPg. J. Virol. 64:1990;2967-2975.
34. Semler B. L., Hanecak R., Anderson C. W., Wimmer E. Cleavage sites in the polyopeptide precursors of poliovirus protein P2-X. Virol. 114:1981;589-594.
35. Toyoda J., Yang C., Takeda N., Nomoto A., Wimmer E. Analysis of RNA synthesis of type 1 poliovirus by using anin vitro. J. Virol. 61:1987;2816-2822.
36. Trautman R., Sutmoller P. Detection and properties of a genomic masked viral particle consisting of foot-and-mouth disease virus nucleic acid in bovine enterovirus protein capsid. Virology. 44:1971;537-543.